Oxytocics

Madhusudan Upadya, Mahesh Nayak

Research output: Contribution to journalArticle

Abstract

Postpartum hemorrhage remains the leading cause of maternal mortality and morbidity. Oxytocic drugs are the main stay in prevention as well as treatment. Oxytocin remains the drug of choice. The use of 5 IU bolus dose has been questioned in recent times. Current evidence suggests infusion to be a preferred choice than bolus dosage. Carbetocin is a newer alternative to oxytocin. Second line drugs include ergot alkaloids (Methyl ergometrine) and prostaglandins (carboprost and misoprostol) which are used as adjuvants to oxytocin in hemorrhage.

Original languageEnglish
Pages (from-to)78-80
Number of pages3
JournalUpdate in Anaesthesia
Volume34
DOIs
Publication statusPublished - 01-01-2019

Fingerprint

Oxytocics
Oxytocin
Carboprost
Ergot Alkaloids
Ergonovine
Postpartum Hemorrhage
Misoprostol
Maternal Mortality
Pharmaceutical Preparations
Prostaglandins
Hemorrhage
Morbidity

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine

Cite this

Upadya, Madhusudan ; Nayak, Mahesh. / Oxytocics. In: Update in Anaesthesia. 2019 ; Vol. 34. pp. 78-80.
@article{b72e0011d84c464cb02fd2642d010445,
title = "Oxytocics",
abstract = "Postpartum hemorrhage remains the leading cause of maternal mortality and morbidity. Oxytocic drugs are the main stay in prevention as well as treatment. Oxytocin remains the drug of choice. The use of 5 IU bolus dose has been questioned in recent times. Current evidence suggests infusion to be a preferred choice than bolus dosage. Carbetocin is a newer alternative to oxytocin. Second line drugs include ergot alkaloids (Methyl ergometrine) and prostaglandins (carboprost and misoprostol) which are used as adjuvants to oxytocin in hemorrhage.",
author = "Madhusudan Upadya and Mahesh Nayak",
year = "2019",
month = "1",
day = "1",
doi = "10.1029/WFSA-D-18-00033",
language = "English",
volume = "34",
pages = "78--80",
journal = "Update in Anaesthesia",
issn = "1353-4882",
publisher = "Roayal Devon and Exeter Healthcare NHS Trust",

}

Oxytocics. / Upadya, Madhusudan; Nayak, Mahesh.

In: Update in Anaesthesia, Vol. 34, 01.01.2019, p. 78-80.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Oxytocics

AU - Upadya, Madhusudan

AU - Nayak, Mahesh

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Postpartum hemorrhage remains the leading cause of maternal mortality and morbidity. Oxytocic drugs are the main stay in prevention as well as treatment. Oxytocin remains the drug of choice. The use of 5 IU bolus dose has been questioned in recent times. Current evidence suggests infusion to be a preferred choice than bolus dosage. Carbetocin is a newer alternative to oxytocin. Second line drugs include ergot alkaloids (Methyl ergometrine) and prostaglandins (carboprost and misoprostol) which are used as adjuvants to oxytocin in hemorrhage.

AB - Postpartum hemorrhage remains the leading cause of maternal mortality and morbidity. Oxytocic drugs are the main stay in prevention as well as treatment. Oxytocin remains the drug of choice. The use of 5 IU bolus dose has been questioned in recent times. Current evidence suggests infusion to be a preferred choice than bolus dosage. Carbetocin is a newer alternative to oxytocin. Second line drugs include ergot alkaloids (Methyl ergometrine) and prostaglandins (carboprost and misoprostol) which are used as adjuvants to oxytocin in hemorrhage.

UR - http://www.scopus.com/inward/record.url?scp=85075613594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075613594&partnerID=8YFLogxK

U2 - 10.1029/WFSA-D-18-00033

DO - 10.1029/WFSA-D-18-00033

M3 - Article

AN - SCOPUS:85075613594

VL - 34

SP - 78

EP - 80

JO - Update in Anaesthesia

JF - Update in Anaesthesia

SN - 1353-4882

ER -